bendroflumethiazide has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PA | 1 |
| Sampson, SA | 1 |
1 other study available for bendroflumethiazide and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Topical non-steroidal drugs are systemically absorbed and may cause renal disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bendroflumethiazide; Biopsy; Diuretics; Fenoprofen; Glomeru | 1999 |